Lee Ju-Hee
Department of Surgery, Hanyang University Hospital, Seoul, Republic of Korea.
Transl Gastroenterol Hepatol. 2016 May 18;1:40. doi: 10.21037/tgh.2016.05.02. eCollection 2016.
Since Korean Laparoscopic Gastrointestinal Surgery Study (KLASS) group was activated in 2003, several randomized controlled trials (RCTs) have finished or are ongoing in Korea to evaluate oncologic safety and feasibility of minimally invasive surgery (MIS) for gastric cancer by KLASS group as well as other expert surgeons. MIS in gastric cancer is regarded as one of standard treatment modality for early gastric cancer (EGC) and the indication is going expansion with the accumulation of evidence. This review covers current status of ongoing clinical trials on MIS for gastric cancer in Korea.
自2003年韩国腹腔镜胃肠手术研究(KLASS)组启动以来,韩国已经完成了多项随机对照试验(RCT),或者仍在进行中,以评估KLASS组以及其他专家外科医生进行的胃癌微创手术(MIS)的肿瘤学安全性和可行性。胃癌的MIS被视为早期胃癌(EGC)的标准治疗方式之一,并且随着证据的积累,其适应证正在不断扩大。这篇综述涵盖了韩国目前正在进行的胃癌MIS临床试验的现状。